You are here

earnings

Pfizer's Covid-19 vaccine captures the most annual sales of any medical product ever — by more than $15B

Endpoints

Tue, 02/8/22 - 10:12 am

Why Shares of PerkinElmer Dropped 14.4% in January

Motley Fool

Mon, 02/7/22 - 10:12 am

Sanofi's Dupixent rolls on, but US flu shots took backseat to COVID-19 boosters in the fourth quarter

Fierce Pharma

Fri, 02/4/22 - 01:06 pm

Eli Lilly (LLY) Q4 Earnings Miss, COVID Therapies Aid Sales

Yahoo/Zacks.com

Thu, 02/3/22 - 11:41 pm

Roche regains pre-pandemic sales footing, highlights bursting pipeline — with one key failure

Endpoints

Thu, 02/3/22 - 11:09 pm

After disastrous start to launch, Biogen still expects 'minimal' sales from Aduhelm this year

Fierce Pharma

Thu, 02/3/22 - 11:45 am

Alzheimer's disease

AbbVie's blockbuster eye drug Restasis under threat as FDA approves Viatris' copycat

Fierce Pharma

Wed, 02/2/22 - 11:50 pm

Omicron Delivers Blow to Boston Sci’s Guidance

Medical Devices and Diagnostics Industry

Wed, 02/2/22 - 11:48 pm

Boston Scientific

AbbVie's Gonzalez: Skyrizi and Rinvoq to become Humira 2.0 — while adding an indication for atopic dermatitis

Endpoints

Wed, 02/2/22 - 11:46 pm

Novartis (NVS) Q4 Earnings & Sales Miss, Sandoz Review Ongoing

NASDAQ

Wed, 02/2/22 - 11:44 pm

Here's What to Know About Vertex Pharmaceuticals' Earnings Report

Motley Fool

Tue, 02/1/22 - 10:31 am

Vertex Pharmaceuticals

Omicron Strikes Stryker, But Mako Saves the Day

Medical Devices and Diagnostics Industry

Mon, 01/31/22 - 11:56 pm

Edwards sees hospital capacity slow TAVR procedures, keeps 2022 guidance

Medtech Dive

Fri, 01/28/22 - 10:19 am

Edwards Lifesciences

Is Abbott Looking for M&A Opportunities?

Medical Devices and Diagnostics Industry

Thu, 01/27/22 - 10:49 am

J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report

CNBC

Tue, 01/25/22 - 11:41 pm

GE Healthcare Revenues Decline by 4%

Medical Devices and Diagnostics Industry

Tue, 01/25/22 - 11:36 pm

Spinoff updates: Merck’s Organon and Novartis’ Sandoz

Generics and Biosimilar Initiative

Mon, 11/29/21 - 11:08 pm

AstraZeneca expects 'modest profitability' for next round of Covid-19 vaccine supply deals — and prunes pipeline in Q3 update

Endpoints

Fri, 11/12/21 - 11:38 am

How Regeneron's Covid Drug Lent Itself To A Big Third-Quarter Beat

Investors Business Daily

Thu, 11/4/21 - 10:41 am

Here's the Single Most Important Detail in Pfizer's Q3 Update

Motley Fool

Thu, 11/4/21 - 10:19 am

Pages